Ausgabe 2/2010
Inhalt (35 Artikel)
Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue
Lindsay-Rae B. Weitzel, Tim Byers, Jenna Allen, Christina Finlayson, Steve M. Helmke, John E. Hokanson, Stephen W. Hunsucker, James R. Murphy, Keri Newell, Kelly M. Queensland, Meenakshi Singh, Paul E. Wischmeyer, Mark W. Duncan, Anthony Elias
The small heat shock protein HspB2 is a novel anti-apoptotic protein that inhibits apical caspase activation in the extrinsic apoptotic pathway
Shayna E. Oshita, Feng Chen, Toni Kwan, Fruma Yehiely, Vincent L. Cryns
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)
F. T. Martin, R. M. Dwyer, J. Kelly, S. Khan, J. M. Murphy, C. Curran, N. Miller, E. Hennessy, P. Dockery, F. P. Barry, T. O’Brien, M. J. Kerin
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
Yesim Gökmen-Polar, Rutika Mehta, Sukru Tuzmen, Spyro Mousses, Mangesh A. Thorat, Kerry L. Sanders, Dmitry Turbin, Samuel Leung, David G. Huntsman, George W. Sledge Jr., Sunil Badve
Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene
Ivana Ticha, Zdenek Kleibl, Jana Stribrna, Jaroslav Kotlas, Martina Zimovjanova, Martin Mateju, Michal Zikan, Petr Pohlreich
Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells
Xu Di, Chris Gennings, Harry D. Bear, Laura J. Graham, Christopher M. Sheth, Kimber L. White Jr., David A. Gewirtz
Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling
Sook Kyung Park, Bob G. Sanders, Kimberly Kline
Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4
Johanna M. Ketolainen, Emma-Leena Alarmo, Vilppu J. Tuominen, Anne Kallioniemi
Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer
Thierry Petit, Marc Wilt, Michel Velten, Jean-François Rodier, Jean-Pierre Fricker, Patrick Dufour, Jean-Pierre Ghnassia
Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis
Shi-Yi Wang, Karen Kuntz, Todd Tuttle, Robert Kane
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm, Volkmar Müller, Bahriye Aktas, Wolfgang Janni, Andreas Schneeweiss, Elmar Stickeler, Claus Lattrich, Christian R. Löhberg, Erich Solomayer, Brigitte Rack, Sabine Riethdorf, Christoph Klein, Christian Schindlbeck, Kerstin Brocker, Sabine Kasimir-Bauer, Diethelm Wallwiener, Klaus Pantel
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?
Christiane Richter-Ehrenstein, Juliane Arndt, Ann-Christin Buckendahl, Jan Eucker, Wilko Weichert, Atsuko Kasajima, Achim Schneider, Aurelia Noske
Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis
Jian Zhang, Li-Xin Qiu, Zhong-Hua Wang, Shiang-Jiin Leaw, Bi-Yun Wang, Jia-Lei Wang, Zhi-Gang Cao, Jia-Li Gao, Xi-Chun Hu
GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis
Jia Hu, Guo-Wu Zhou, Ning Wang, Ya-Jie Wang
Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer
Song Yao, William E. Barlow, Kathy S. Albain, Ji-Yeob Choi, Hua Zhao, Robert B. Livingston, Warren Davis, James M. Rae, I-Tien Yeh, Laura F. Hutchins, Peter M. Ravdin, Silvana Martino, Alan P. Lyss, C. Kent Osborne, Martin D. Abeloff, Gabriel N. Hortobagyi, Daniel F. Hayes, Christine B. Ambrosone
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis
Patricia G. Moorman, Edwin S. Iversen, P. Kelly Marcom, Jeffrey R. Marks, Frances Wang, Eunjung Lee, Giske Ursin, Timothy R. Rebbeck, Susan M. Domchek, Banu Arun, Lisa Susswein, Claudine Isaacs, Judy E. Garber, Kala Visvanathan, Constance A. Griffin, Rebecca Sutphen, Jennifer Brzosowicz, Stephen Gruber, Dianne M. Finkelstein, Joellen M. Schildkraut
Transforming growth factorβ1 L10P variant plays an active role on the breast cancer susceptibility in Caucasian: evidence from 10,392 cases and 11,697 controls
Xiangyu Ma, Chunhai Chen, Hongyan Xiong, Yafei Li
Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer
Stacey Shiovitz, Jessica Everett, Shu-chen Huang, Mohammed S. Orloff, Charis Eng, Stephen B. Gruber
Genetic influences on mammographic density in Korean twin and family: the Healthy Twin study
Joohon Sung, Yun-Mi Song, Jennifer Stone, Kayoung Lee, Ji-in Jeong, Sung-Soo Kim
The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51,236 subjects
Li-Xin Qiu, Jian Zhang, Xiao-Dong Zhu, Chun-Lei Zheng, Si Sun, Zhong-Hua Wang, Xin-Min Zhao, Jia-Lei Wang, Lei-Ping Wang, Hui Yu, Kai Xue, Xi-Chun Hu
Association of a TGF-β1 gene −509 C/T polymorphism with breast cancer risk: a meta-analysis
Sang Uk Woo, Kyong Hwa Park, Ok Hee Woo, Dae Sik Yang, Ae-Ree Kim, Eun Sook Lee, Jae-Bok Lee, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo
Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ
Brian L. Sprague, Amy Trentham-Dietz, Hazel B. Nichols, John M. Hampton, Polly A. Newcomb
Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost–effectiveness analysis of different predictive assay strategies
Patricia R. Blank, Matthias Schwenkglenks, Holger Moch, Thomas D. Szucs
Predictors of breast cancer screening behavior in women with a strong family history of the disease
Melanie A. Price, Phyllis N. Butow, Margaret Charles, Tracey Bullen, Bettina Meiser, Joanne M. McKinley, Sue-Anne McLachlan, Kelly-Anne Phillips
Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer
Chenyou Jia, Yu Cai, Yushui Ma, Da Fu
Erratum to: Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer
Chengyou Jia, Yu Cai, Yushui Ma, Da Fu
Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer
Noel Pabalan, Ofelia Francisco-Pabalan, Lillian Sung, Hamdi Jarjanazi, Hilmi Ozcelik
Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer
Dmitri Pchejetski, Joao Nunes, Lysann Sauer, Jasmin Sidhu, Anand Sharma, Hector C. Keun, Jonathan Waxman, Justin Stebbing
Predicting breast cancer risk using mammographic density measurements from both mammogram sides and views
Jennifer Stone, Jane Ding, Ruth M. L. Warren, Stephen W. Duffy
DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast
Katie T. Huang, Alexander Dobrovic, Max Yan, Rooshdiya Z. Karim, C. Soon Lee, Sunil R. Lakhani, Stephen B. Fox
ROCK: a breast cancer functional genomics resource
David Sims, Borisas Bursteinas, Qiong Gao, Ekta Jain, Alan MacKay, Costas Mitsopoulos, Marketa Zvelebil
Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population
Jing Zhang, James D. Fackenthal, Dezheng Huo, Yonglan Zheng, Olufunmilayo I. Olopade
Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
Peter Kang, Shivaani Mariapun, Sze Yee Phuah, Linda Shushan Lim, Jianjun Liu, Sook-Yee Yoon, Meow Keong Thong, Nur Aishah Mohd Taib, Cheng Har Yip, Soo-Hwang Teo
Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer
Yuan Yao, Angela M. H. Brodie, Nancy E. Davidson, Thomas W. Kensler, Qun Zhou
Association of CYP1B1 with hypersensitivity induced by Taxane therapy in breast cancer patients
Roberta Rizzo, Federica Spaggiari, Monica Indelli, Giorgio Lelli, Olavio R. Baricordi, Paola Rimessi, Alessandra Ferlini